Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Waterman

Sports Medicine Winston Salem, NC Medical Doctor

NPI 1518158724 CMS profile 22731

1901 Mooney St, Winston Salem, NC 27103

Open in the dashboard

General payments

$360,488

452 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$105,428 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Brian Waterman of Winston Salem, NC is reported in the CMS Open Payments database as having received $360,488 across 452 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $105,428 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $100,178 77
2024 General $99,225 100
2023 General $67,949 109
2022 General $29,710 54
2021 General $28,552 57
2020 General $18,751 19
2019 General $16,123 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Waterman
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Brian Waterman were reported at $100,178. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Brian Waterman Sports Medicine median Middle half National median
2019 $16,123 $1,176 $199–$4,249 $163
2020 $18,751 $708 $96–$2,890 $114
2021 $28,552 $1,213 $152–$3,994 $132
2022 $29,710 $1,230 $159–$3,998 $149
2023 $67,949 $584 $146–$2,836 $160
2024 $99,225 $628 $163–$3,168 $164
2025 $100,178 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $202,601 235 payments
  2. Vericel Corporation $128,491 100 payments
  3. FH Orthopedics, Inc. $9,551 7 payments
  4. Piedmont Plus Innovation $3,865 36 payments
  5. SouthTech Orthopedics $3,574 7 payments
  6. DePuy Synthes Products, Inc. $2,250 2 payments
  7. Musculoskeletal Transplant Foundation Inc. $2,000 3 payments
  8. Peerless Surgical Inc. $1,582 5 payments
  9. Stryker Corporation $1,527 13 payments
  10. Smith+Nephew, Inc. $1,485 15 payments
  11. Other $3,562 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $164,104 26 payments
  2. Consulting Fee $66,961 33 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $45,341 19 payments
  4. Honoraria $30,175 14 payments
  5. Travel and Lodging $28,937 97 payments
  6. Food and Beverage $12,533 256 payments
  7. Education $12,435 7 payments
Products named General payments · program years 2019–2025
  1. MACI Orthopedics $101,761 72 payments
  2. MACI Cellular Therapy $13,808 17 payments
  3. MACI Cellular Therapy $7,117 4 payments
  4. Arrow $6,629 2 payments
  5. Bioknotless Ethibond $2,048 2 payments
  6. Equinoxe $404 4 payments
  7. INSPACE $371 3 payments
  8. AEQUALIS PERFORM $292 3 payments
  9. ALLOGRAFT TISSUE $255 2 payments
  10. Bioinductive Implant with Arthroscopic Delivery System - Medium $247 2 payments
  11. Other $4,249 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$53,991

Of which drugs: $95

Medicare patients

130

Average age 71

Services billed

538

65 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 72%
High blood pressure 66%
Depression 31%
Diabetes 27%
Ischemic heart disease 24%
Chronic kidney disease 18%
Osteoporosis 17%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 29 129 $95

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

452 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record